Streamline Health Solutions (STRM) Stock Price, News & Analysis

Company Overview

Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management. It also provides auditing and coding, software, and professional services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.

Key Stats

• Today's Range: $2.07 to $2.18
• 50-Day Range: $1.86 to $3.24
• 52-Week Range: $1.82 to $9.75
• Volume: 28,964 shs
• Average Volume: 22,940 shs
• Market Capitalization: $9.19 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

STRM Stock Analysis - Frequently Asked Questions

How have STRM shares performed this year?

Streamline Health Solutions' stock was trading at $3.76 on January 1st, 2025. Since then, STRM stock has decreased by 42.8% and is now trading at $2.15.
View the best growth stocks for 2025 here.

How were Streamline Health Solutions' earnings last quarter?

Streamline Health Solutions, Inc. (NASDAQ:STRM) issued its quarterly earnings results on Thursday, May, 1st. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.42) by $0.10. The company earned $4.70 million during the quarter, compared to the consensus estimate of $4.70 million. Streamline Health Solutions had a negative net margin of 50.51% and a negative trailing twelve-month return on equity of 56.96%.
Read the conference call transcript.

When did Streamline Health Solutions' stock split?

Streamline Health Solutions's stock reverse split on the morning of Friday, October 4th 2024. The 1-15 reverse split was announced on Thursday, September 26th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Who are Streamline Health Solutions' major shareholders?

Top institutional shareholders of Streamline Health Solutions include Nicholas Hoffman & Company LLC. (1.22%). Insiders that own company stock include Kenan Lucas and Benjamin Louis Stilwill.
View institutional ownership trends.

How do I buy shares of Streamline Health Solutions?

Shares of STRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Streamline Health Solutions own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Streamline Health Solutions investors own include Energy Transfer (ET), Ford Motor (F), C3.ai (AI), Alphabet (GOOG), Gevo (GEVO), Inovio Pharmaceuticals (INO) and Exxon Mobil (XOM).

Company Calendar

• Last Earnings: 5/01/2025
• Today: 5/27/2025
• Next Earnings (Estimated): 6/17/2025
• Fiscal Year End: 1/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Computer integrated systems design
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:STRM
• CIK: 1008586
• Web: www.streamlinehealth.net
• Phone: (888) 997-8732
• Fax: N/A
• Employees: 130
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($2.63)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-18,700,000.00
• Net Margins: -50.51%
• Pretax Margin: -50.44%
• Return on Equity: -56.96%
• Return on Assets: -23.70%

Debt

• Debt-to-Equity Ratio: 0.72
• Current Ratio: 0.46
• Quick Ratio: 0.46

Sales & Book Value

• Annual Sales: $17.90 million
• Price / Sales: 0.51
• Cash Flow: $0.95 per share
• Price / Cash Flow: 2.27
• Book Value: $4.79 per share
• Price / Book: 0.45

Miscellaneous

• Outstanding Shares: 4,273,000
• Free Float: 2,966,000
• Market Cap: $9.19 million
• Optionable: Not Optionable
• Beta: 1.78